OrphoMed, Inc.
Industry
- Pharmaceuticals
- Biotechnology
Latest on OrphoMed, Inc.
Neurimmune, Ethris Partner On Inhaled Antibody To Treat COVID-19 Neurimmune AG in Zurich, Switzerland and Ethris GmbH in Munich, Germany announced on 1 April that they have agreed to collaborate o
Big changes were announced at Oculis : the Icelandic clinical-stage biotech named Riad Sherif chief executive officer, succeeding Páll Ragnar Jóhannesson who becomes chief financial officer and
Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging bio
Bicycle Therapeutics Ltd. raised a $52m Series B venture capital round to take the first drug candidates from its bicyclic peptide platform into the clinic, starting later this year. CEO Kevin Lee s